<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on August 3, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-8</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Bausch Health Companies Inc. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 12pt; text-align: center; width: 50%"><FONT STYLE="font-size: 10pt"><B>British Columbia, Canada</B></FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center; width: 50%"><FONT STYLE="font-size: 10pt"><B>98-0448205</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction of <BR>
Incorporation or Organization)</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer <BR>
Identification No.)</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2150
St. Elz&eacute;ar Blvd. West</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Laval, Quebec</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Canada, H7L 4A8</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>(514) 744-6792</B>&#9;&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(Address of Principal Executive Offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Bausch Health Companies Inc. 2014 Omnibus Incentive
Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full Title of the Plan)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tom G. Vadaketh<BR>
    Executive Vice President, Chief Financial Officer </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Bausch Health Companies Inc.<BR>
    c/o Bausch Health US, LLC</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>400 Somerset Corporate Blvd.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Bridgewater, NJ 08807</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>(866) 246-8245 </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">(Name, Address, Including
    Zip Code, and Telephone Number, Including Area Code, of Agent For Service)</P></TD>
    <TD STYLE="font-size: 12pt; text-align: center">&nbsp;</TD></TR>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
&ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer, &rdquo; &ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth
company&rdquo; in Rule 12b-2 of the Exchange Act.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt; width: 60%"><FONT STYLE="font-size: 10pt"><B>Large accelerated filer </B><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></FONT></TD>
    <TD STYLE="font-size: 12pt; width: 40%"><FONT STYLE="font-size: 10pt"><B>Accelerated filer </B><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Non-accelerated filer </B><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT><B>
    (Do not check if a smaller reporting company)</B></FONT></TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Smaller reporting company </B><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Emerging Growth Company </B><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="background-color: white">This Registration
Statement has been prepared and filed pursuant to and in accordance with the requirements of General Instruction E to Form S-8 for the
purpose of registering an additional </FONT>7,500,000 <FONT STYLE="background-color: white">Common Shares, no par value (&ldquo;Common
Shares&rdquo;), of Bausch Health Companies Inc. (the &ldquo;Company&rdquo; or &ldquo;Registrant&rdquo;) that are issuable at any time
or from time to time under the Bausch Health Companies Inc. 2014 Omnibus Incentive Plan, as amended and restated effective as of May 16,
2023 (the &ldquo;Plan&rdquo;),</FONT>&nbsp;and any additional Common Shares that become issuable under the Plan by reason of any stock
dividend, stock split, or other similar transaction pursuant to Rule&nbsp;416(a)&nbsp;under the&nbsp;Securities Act of 1933, as amended
(the &ldquo;Securities Act&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="background-color: white">Pursuant
to General Instruction E, the contents of the Registration Statements on Form S-8 filed for the Plan with the Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) on May 21, 2014 (Registration No. 333-196120), August 10, 2018 (Registration No. 333-226786),
May 7, 2020 (Registration No. 333-226786) and August 9, 2022 (Registration No. 333- 264728),&nbsp;including the documents incorporated
by reference therein, are incorporated by reference into this Registration Statement on Form S-8 (this &ldquo;Registration Statement&rdquo;),
except as supplemented by the information set forth below.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><B>INFORMATION REQUIRED IN
THE SECTION 10(a) PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The information specified in Item 1 and Item 2
of Part I of Form S-8 is omitted from this Registration Statement in accordance with the provisions of Rule 428 under the Securities Act,
and the introductory note to Part I of the Form S-8 instructions. The documents containing the information specified in Part I of Form
S-8 will be delivered to the participants in the Plan, as specified by Rule 428(b)(1) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II<BR>
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 3. Incorporation of Documents by Reference.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following documents are incorporated herein
by reference:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(a) The Company&rsquo;s Annual Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000885590/000088559023000009/bhc-20221231.htm">Form 10-K</A> for the year ended December 31, 2022, filed with the Commission on February 23, 2023 (the &ldquo;Annual Report&rdquo;), including
the sections of the Registrant&rsquo;s Definitive Proxy Statement on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000885590/000114036123017057/ny20007033x1_def14a.htm">Schedule 14A</A> for the Registrant&rsquo;s 2023 Annual Meeting of Stockholders,
as filed with the Commission on April 6, 2023, incorporated by reference in the Annual Report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b) The Company&rsquo;s Quarterly Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/885590/000088559023000018/bhc-20230331.htm">Form 10-Q for the quarter ended March 31, 2023, filed with the Commission on May 4, 2023</A>, and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000885590/000088559023000028/bhc-20230630.htm">for the quarter ended June 30, 2023, filed with the Commission on August 3, 2023</A>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(c)&#8239;The
Company&rsquo;s Current Reports on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000885590/000088559023000012/bhc-20230301.htm">Form 8-K filed with the Commission on March 1, 2023</A> (except for the information furnished under Item
7.01), <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000885590/000088559023000021/bhc-20230517.htm">May 17, 2023</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000885590/000119312523179648/d520803d8k.htm">June 30, 2023</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000885590/000119312523183310/d478804d8k.htm">July 7, 2023</A> (except for the information furnished under Item 7.01) and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000885590/000119312523183312/d527430d8k.htm">July 7, 2023</A>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(d) The description of the Common Shares contained
in the Company&rsquo;s Registration Statement on Form 8-A12B/A filed with the Commission on May 20, 2014 and any amendment or report filed
for the purpose of updating such description.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, all documents subsequently filed by
the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the&nbsp;Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered
have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration
Statement and to be a part hereof from the date of the filing of such documents. Any statement contained in a document incorporated or
deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein (or in any other subsequently filed document which also is incorporated or deemed to be
incorporated by reference herein), modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 5. Interests of Named Experts and Counsel.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8. Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font-size: 10pt">Exhibit Number </FONT></TD>
    <TD STYLE="width: 90%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000119312513331879/d583672dex31.htm"><FONT STYLE="font-size: 10pt">4.1</FONT></A></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000119312513331879/d583672dex31.htm"><FONT STYLE="font-size: 10pt">Certificate of Continuation, dated August 9, 2013, filed as Exhibit 3.1 to the Company&rsquo;s
    Current Report on Form 8-K filed on August 13, 2013.</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000095010318008539/dp93294_ex0301.htm"><FONT STYLE="font-size: 10pt">4.2</FONT></A></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000095010318008539/dp93294_ex0301.htm"><FONT STYLE="font-size: 10pt">Notice of Articles of Bausch Health Companies Inc., as of July 16, 2018, filed as Exhibit 3.1 to
    the Company&rsquo;s Current Report on Form 8-K filed on July 16, 2018.</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000095010318008539/dp93294_ex0302.htm"><FONT STYLE="font-size: 10pt">4.3</FONT></A></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/885590/000095010318008539/dp93294_ex0302.htm"><FONT STYLE="font-size: 10pt">Articles of the Company, as of July 13, 2018 and dated August 8, 2013, filed as Exhibit 3.2 to
    the Company&rsquo;s Current Report on Form 8-K filed on July 16, 2018.</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="dp197294_ex0501.htm"><FONT STYLE="font-size: 10pt">5.1*</FONT></A></TD>
    <TD><A HREF="dp197294_ex0501.htm"><FONT STYLE="font-size: 10pt">Opinion of Osler, Hoskin &amp; Harcourt LLP</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="dp197294_ex2301.htm"><FONT STYLE="font-size: 10pt">23.1*</FONT></A></TD>
    <TD><A HREF="dp197294_ex2301.htm"><FONT STYLE="font-size: 10pt">Consent of PricewaterhouseCoopers LLP</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="dp197294_ex0501.htm"><FONT STYLE="font-size: 10pt">23.2*</FONT></A></TD>
    <TD><A HREF="dp197294_ex0501.htm"><FONT STYLE="font-size: 10pt">Consent of Osler, Hoskin &amp; Harcourt LLP (included in Exhibit 5.1)</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="#Signatures"><FONT STYLE="font-size: 10pt">24*</FONT></A></TD>
    <TD><A HREF="#Signatures"><FONT STYLE="font-size: 10pt">Powers of Attorney (included in signature pages hereof)</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="dp197294_ex9900.htm"><FONT STYLE="font-size: 10pt">99*</FONT></A></TD>
    <TD><A HREF="dp197294_ex9900.htm"><FONT STYLE="font-size: 10pt">Bausch Health Companies Inc. 2014 Omnibus Incentive Plan, as amended and restated effective as
    of May 16, 2023.</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><A HREF="dp197294_exfilingfees.htm"><FONT STYLE="font-size: 10pt">107*</FONT></A></TD>
    <TD><A HREF="dp197294_exfilingfees.htm"><FONT STYLE="font-size: 10pt">Filing Fee Table</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Filed herewith.</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="Signatures" TITLE="Signatures"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Bridgewater, State of New Jersey, on August 3, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>BAUSCH HEALTH COMPANIES INC. </B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Thomas J. Appio</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-size: 10pt">Thomas J. Appio</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer (Principal Executive Officer)</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>BAUSCH HEALTH US, LLC,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>as Authorized Representative in the United States</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Tom G. Vadaketh </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-size: 10pt">Tom G. Vadaketh</FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="width: 40%">
    Executive Vice President, Chief Financial Officer on behalf of Bausch Health US, LLC
</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned directors and officers of Bausch
Health Companies Inc. hereby appoint each of Thomas J. Appio and Tom Vadaketh as attorneys-in-fact for the undersigned, with full power
of substitution for, and in the name, place and stead of the undersigned, to sign and file with the Securities and Exchange Commission
under the&nbsp;Securities Act of 1933, any and all amendments (including post-effective amendments) and exhibits to this Registration
Statement on Form S-8 (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule&nbsp;462(b)&nbsp;under
the&nbsp;Securities Act of 1933) and any and all applications and other documents to be filed with the Securities and Exchange Commission
pertaining to the registration of the securities covered hereby, with full power and authority to do and perform any and all acts and
things whatsoever requisite and necessary or desirable, hereby ratifying and confirming all that said attorney-in-fact, or his her substitute
or substitutes, may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the&nbsp;Securities Act&nbsp;of 1933,
this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; width: 25%; vertical-align: middle">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Signature</B></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; width: 50%; vertical-align: middle">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Title</B></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; white-space: nowrap; width: 25%; vertical-align: middle">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date</B></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Thomas J. Appio</FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center; width: 50%; vertical-align: middle">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chief Executive Officer and Director</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(principal executive officer)</P></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Thomas J. Appio</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Tom G. Vadaketh</FONT></TD>
    <TD ROWSPAN="3" STYLE="text-align: center; width: 50%; vertical-align: middle">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Executive Vice President,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chief Financial Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(principal financial officer)</P></TD>
    <TD ROWSPAN="3" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Tom G. Vadaketh</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ John S. Barresi</FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center; width: 50%; vertical-align: middle">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Senior Vice President, Controller and Chief Accounting
    Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(principal accounting officer)</P></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">John S. Barresi</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ John A. Paulson</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 50%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Chairman of the Board</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">John A. Paulson</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Brett M. Icahn</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 50%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Brett M. Icahn</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Sarah B. Kavanagh</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 50%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Sarah B. Kavanagh</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Steven D. Miller</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 50%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Steven D. Miller</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Dr. Richard C. Mulligan</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 50%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Dr. Richard C. Mulligan</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Robert N. Power</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 50%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Robert N. Power</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Russel C. Robertson</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 50%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Russel C. Robertson</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Thomas W. Ross, Sr.</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 50%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Thomas W. Ross, Sr.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Amy B. Wechsler, M.D.</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 50%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: middle; width: 25%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">August 3, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Amy B. Wechsler, M.D.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "dp197294_s8.htm", "description": "FORM S-8", "secsgml_size_bytes": 41407}]
{"company-data": {"conformed-name": "Bausch Health Companies Inc.", "cik": "0000885590", "assigned-sic": "2834", "irs-number": "000000000", "state-of-incorporation": "NJ", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-273673", "film-number": "231141305"}, "business-address": {"street1": "2150 ST. ELZEAR BLVD. WEST", "street2": "LAVAL", "city": "QUEBEC", "state": "A8", "zip": "H7L 4A8", "phone": "514-744-6792"}, "mail-address": {"street1": "2150 ST. ELZEAR BLVD. WEST", "street2": "LAVAL", "city": "QUEBEC", "state": "A8", "zip": "H7L 4A8"}, "former-company": [{"former-conformed-name": "Valeant Pharmaceuticals International, Inc.", "date-changed": "20100928"}, {"former-conformed-name": "BIOVAIL Corp", "date-changed": "20100416"}, {"former-conformed-name": "BIOVAIL CORP INTERNATIONAL", "date-changed": "19960522"}]}
As filed with the Securities and Exchange Commission
on August 3, 2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
Bausch Health Companies Inc.
(Exact Name of Registrant as Specified in its Charter)
British Columbia, Canada
98-0448205
(State or Other Jurisdiction of
Incorporation or Organization)
(I.R.S. Employer
Identification No.)
2150
St. Elzéar Blvd. West
Laval, Quebec
Canada, H7L 4A8
(514) 744-6792
(Address of Principal Executive Offices)
Bausch Health Companies Inc. 2014 Omnibus Incentive
Plan
(Full Title of the Plan)
Tom G. Vadaketh
Executive Vice President, Chief Financial Officer
Bausch Health Companies Inc.
c/o Bausch Health US, LLC
400 Somerset Corporate Blvd.
Bridgewater, NJ 08807
(866) 246-8245
(Name, Address, Including
    Zip Code, and Telephone Number, Including Area Code, of Agent For Service)
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
"large accelerated filer," "accelerated filer, " "smaller reporting company" and "emerging growth
company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
(Do not check if a smaller reporting company)
Smaller reporting company
☐
Emerging Growth Company
☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act.
☐
EXPLANATORY NOTE
This Registration
Statement has been prepared and filed pursuant to and in accordance with the requirements of General Instruction E to Form S-8 for the
purpose of registering an additional
7,500,000
Common Shares, no par value ("Common
Shares"), of Bausch Health Companies Inc. (the "Company" or "Registrant") that are issuable at any time
or from time to time under the Bausch Health Companies Inc. 2014 Omnibus Incentive Plan, as amended and restated effective as of May 16,
2023 (the "Plan"),
and any additional Common Shares that become issuable under the Plan by reason of any stock
dividend, stock split, or other similar transaction pursuant to Rule 416(a) under the Securities Act of 1933, as amended
(the "Securities Act").
Pursuant
to General Instruction E, the contents of the Registration Statements on Form S-8 filed for the Plan with the Securities and Exchange
Commission (the "Commission") on May 21, 2014 (Registration No. 333-196120), August 10, 2018 (Registration No. 333-226786),
May 7, 2020 (Registration No. 333-226786) and August 9, 2022 (Registration No. 333- 264728), including the documents incorporated
by reference therein, are incorporated by reference into this Registration Statement on Form S-8 (this "Registration Statement"),
except as supplemented by the information set forth below.
PART I
INFORMATION REQUIRED IN
THE SECTION 10(a) PROSPECTUS
The information specified in Item 1 and Item 2
of Part I of Form S-8 is omitted from this Registration Statement in accordance with the provisions of Rule 428 under the Securities Act,
and the introductory note to Part I of the Form S-8 instructions. The documents containing the information specified in Part I of Form
S-8 will be delivered to the participants in the Plan, as specified by Rule 428(b)(1) under the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents are incorporated herein
by reference:
(a) The Company's Annual Report on
Form 10-K
for the year ended December 31, 2022, filed with the Commission on February 23, 2023 (the "Annual Report"), including
the sections of the Registrant's Definitive Proxy Statement on
Schedule 14A
for the Registrant's 2023 Annual Meeting of Stockholders,
as filed with the Commission on April 6, 2023, incorporated by reference in the Annual Report;
(b) The Company's Quarterly Report on
Form 10-Q for the quarter ended March 31, 2023, filed with the Commission on May 4, 2023
, and
for the quarter ended June 30, 2023, filed with the Commission on August 3, 2023
;
(c) The
Company's Current Reports on
Form 8-K filed with the Commission on March 1, 2023
(except for the information furnished under Item
7.01),
May 17, 2023
,
June 30, 2023
,
July 7, 2023
(except for the information furnished under Item 7.01) and
July 7, 2023
; and
(d) The description of the Common Shares contained
in the Company's Registration Statement on Form 8-A12B/A filed with the Commission on May 20, 2014 and any amendment or report filed
for the purpose of updating such description.
In addition, all documents subsequently filed by
the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered
have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration
Statement and to be a part hereof from the date of the filing of such documents. Any statement contained in a document incorporated or
deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein (or in any other subsequently filed document which also is incorporated or deemed to be
incorporated by reference herein), modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this Registration Statement.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 8. Exhibits.
Exhibit Number
4.1
Certificate of Continuation, dated August 9, 2013, filed as Exhibit 3.1 to the Company's
    Current Report on Form 8-K filed on August 13, 2013.
4.2
Notice of Articles of Bausch Health Companies Inc., as of July 16, 2018, filed as Exhibit 3.1 to
    the Company's Current Report on Form 8-K filed on July 16, 2018.
4.3
Articles of the Company, as of July 13, 2018 and dated August 8, 2013, filed as Exhibit 3.2 to
    the Company's Current Report on Form 8-K filed on July 16, 2018.
5.1*
Opinion of Osler, Hoskin & Harcourt LLP
23.1*
Consent of PricewaterhouseCoopers LLP
23.2*
Consent of Osler, Hoskin & Harcourt LLP (included in Exhibit 5.1)
24*
Powers of Attorney (included in signature pages hereof)
99*
Bausch Health Companies Inc. 2014 Omnibus Incentive Plan, as amended and restated effective as
    of May 16, 2023.
107*
Filing Fee Table
* Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Bridgewater, State of New Jersey, on August 3, 2023.
BAUSCH HEALTH COMPANIES INC.
By:
/s/ Thomas J. Appio
Name:
Thomas J. Appio
Title:
Chief Executive Officer (Principal Executive Officer)
BAUSCH HEALTH US, LLC,
as Authorized Representative in the United States
By:
/s/ Tom G. Vadaketh
Name:
Tom G. Vadaketh
Title:
Executive Vice President, Chief Financial Officer on behalf of Bausch Health US, LLC
POWER OF ATTORNEY
The undersigned directors and officers of Bausch
Health Companies Inc. hereby appoint each of Thomas J. Appio and Tom Vadaketh as attorneys-in-fact for the undersigned, with full power
of substitution for, and in the name, place and stead of the undersigned, to sign and file with the Securities and Exchange Commission
under the Securities Act of 1933, any and all amendments (including post-effective amendments) and exhibits to this Registration
Statement on Form S-8 (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under
the Securities Act of 1933) and any and all applications and other documents to be filed with the Securities and Exchange Commission
pertaining to the registration of the securities covered hereby, with full power and authority to do and perform any and all acts and
things whatsoever requisite and necessary or desirable, hereby ratifying and confirming all that said attorney-in-fact, or his her substitute
or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933,
this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
/s/ Thomas J. Appio
Chief Executive Officer and Director
(principal executive officer)
August 3, 2023
Thomas J. Appio
/s/ Tom G. Vadaketh
Executive Vice President,
Chief Financial Officer
(principal financial officer)
August 3, 2023
Tom G. Vadaketh
/s/ John S. Barresi
Senior Vice President, Controller and Chief Accounting
    Officer
(principal accounting officer)
August 3, 2023
John S. Barresi
/s/ John A. Paulson
Chairman of the Board
August 3, 2023
John A. Paulson
/s/ Brett M. Icahn
Director
August 3, 2023
Brett M. Icahn
/s/ Sarah B. Kavanagh
Director
August 3, 2023
Sarah B. Kavanagh
/s/ Steven D. Miller
Director
August 3, 2023
Steven D. Miller
/s/ Dr. Richard C. Mulligan
Director
August 3, 2023
Dr. Richard C. Mulligan
/s/ Robert N. Power
Director
August 3, 2023
Robert N. Power
/s/ Russel C. Robertson
Director
August 3, 2023
Russel C. Robertson
/s/ Thomas W. Ross, Sr.
Director
August 3, 2023
Thomas W. Ross, Sr.
/s/ Amy B. Wechsler, M.D.
Director
August 3, 2023
Amy B. Wechsler, M.D.